Biological removal processes in aerobic granular sludge exposed to diclofenac

Detalhes bibliográficos
Autor(a) principal: Bessa, Vânia S.
Data de Publicação: 2021
Outros Autores: Moreira, Irina S., Loosdrecht, Mark C. M. van, Castro, Paula M. L.
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: http://hdl.handle.net/10400.14/33167
Resumo: Diclofenac is a worldwide consumed drug included in the watch list of substances to be monitored according to the European Union Water Framework Directive (Directive 2013/39/EU). Aerobic granular sludge sequencing batch reactors (AGS-SBR) are increasingly used for wastewater treatment but there is scant information on the fate and effect of micropollutants to nutrient removal processes. An AGS-SBR fed with synthetic wastewater containing diclofenac was bioaugmented with a diclofenac degrading bacterial strain and performance and microbial community dynamics was analysed. Chemical oxygen demand, phosphate and ammonia removal were not affected by the micropollutant at 0.03 mM (9.54 mg L-1). The AGS was able to retain the degrading strain, which was detected in the sludge throughout after augmentation. Nevertheless, besides some adsorption to the biomass, diclofenac was not degraded by the augmented sludge given the short operating cycles and even if batch degradation assays confirmed that the bioaugmented AGS was able to biodegrade the compound. The exposure to the pharmaceutical affected the microbial community of the sludge, separating the two first phases of reactor operation (acclimatization and granulation) from subsequent phases. The AGS was able to keep the bioaugmented strain and to maintain the main functions of nutrient removal even through the long exposure to the pharmaceutical, but combined strategies are needed to reduce the spread of micropollutants in the environment.
id RCAP_5251ded21fe21cecbd3126c3a5d9fb9e
oai_identifier_str oai:repositorio.ucp.pt:10400.14/33167
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Biological removal processes in aerobic granular sludge exposed to diclofenacDiclofenacLabrys portucalensis F11Aerobic granular sludge sequencing batch reactorBioaugmentationPerformanceDiclofenac is a worldwide consumed drug included in the watch list of substances to be monitored according to the European Union Water Framework Directive (Directive 2013/39/EU). Aerobic granular sludge sequencing batch reactors (AGS-SBR) are increasingly used for wastewater treatment but there is scant information on the fate and effect of micropollutants to nutrient removal processes. An AGS-SBR fed with synthetic wastewater containing diclofenac was bioaugmented with a diclofenac degrading bacterial strain and performance and microbial community dynamics was analysed. Chemical oxygen demand, phosphate and ammonia removal were not affected by the micropollutant at 0.03 mM (9.54 mg L-1). The AGS was able to retain the degrading strain, which was detected in the sludge throughout after augmentation. Nevertheless, besides some adsorption to the biomass, diclofenac was not degraded by the augmented sludge given the short operating cycles and even if batch degradation assays confirmed that the bioaugmented AGS was able to biodegrade the compound. The exposure to the pharmaceutical affected the microbial community of the sludge, separating the two first phases of reactor operation (acclimatization and granulation) from subsequent phases. The AGS was able to keep the bioaugmented strain and to maintain the main functions of nutrient removal even through the long exposure to the pharmaceutical, but combined strategies are needed to reduce the spread of micropollutants in the environment.Veritati - Repositório Institucional da Universidade Católica PortuguesaBessa, Vânia S.Moreira, Irina S.Loosdrecht, Mark C. M. vanCastro, Paula M. L.2021-05-23T15:52:55Z2022-09-192022-09-19T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleapplication/pdfhttp://hdl.handle.net/10400.14/33167eng0959-333010.1080/09593330.2021.19210488510653656333902395000654258800001info:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2024-09-06T12:32:13Zoai:repositorio.ucp.pt:10400.14/33167Portal AgregadorONGhttps://www.rcaap.pt/oai/openairemluisa.alvim@gmail.comopendoar:71602024-09-06T12:32:13Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Biological removal processes in aerobic granular sludge exposed to diclofenac
title Biological removal processes in aerobic granular sludge exposed to diclofenac
spellingShingle Biological removal processes in aerobic granular sludge exposed to diclofenac
Bessa, Vânia S.
Diclofenac
Labrys portucalensis F11
Aerobic granular sludge sequencing batch reactor
Bioaugmentation
Performance
title_short Biological removal processes in aerobic granular sludge exposed to diclofenac
title_full Biological removal processes in aerobic granular sludge exposed to diclofenac
title_fullStr Biological removal processes in aerobic granular sludge exposed to diclofenac
title_full_unstemmed Biological removal processes in aerobic granular sludge exposed to diclofenac
title_sort Biological removal processes in aerobic granular sludge exposed to diclofenac
author Bessa, Vânia S.
author_facet Bessa, Vânia S.
Moreira, Irina S.
Loosdrecht, Mark C. M. van
Castro, Paula M. L.
author_role author
author2 Moreira, Irina S.
Loosdrecht, Mark C. M. van
Castro, Paula M. L.
author2_role author
author
author
dc.contributor.none.fl_str_mv Veritati - Repositório Institucional da Universidade Católica Portuguesa
dc.contributor.author.fl_str_mv Bessa, Vânia S.
Moreira, Irina S.
Loosdrecht, Mark C. M. van
Castro, Paula M. L.
dc.subject.por.fl_str_mv Diclofenac
Labrys portucalensis F11
Aerobic granular sludge sequencing batch reactor
Bioaugmentation
Performance
topic Diclofenac
Labrys portucalensis F11
Aerobic granular sludge sequencing batch reactor
Bioaugmentation
Performance
description Diclofenac is a worldwide consumed drug included in the watch list of substances to be monitored according to the European Union Water Framework Directive (Directive 2013/39/EU). Aerobic granular sludge sequencing batch reactors (AGS-SBR) are increasingly used for wastewater treatment but there is scant information on the fate and effect of micropollutants to nutrient removal processes. An AGS-SBR fed with synthetic wastewater containing diclofenac was bioaugmented with a diclofenac degrading bacterial strain and performance and microbial community dynamics was analysed. Chemical oxygen demand, phosphate and ammonia removal were not affected by the micropollutant at 0.03 mM (9.54 mg L-1). The AGS was able to retain the degrading strain, which was detected in the sludge throughout after augmentation. Nevertheless, besides some adsorption to the biomass, diclofenac was not degraded by the augmented sludge given the short operating cycles and even if batch degradation assays confirmed that the bioaugmented AGS was able to biodegrade the compound. The exposure to the pharmaceutical affected the microbial community of the sludge, separating the two first phases of reactor operation (acclimatization and granulation) from subsequent phases. The AGS was able to keep the bioaugmented strain and to maintain the main functions of nutrient removal even through the long exposure to the pharmaceutical, but combined strategies are needed to reduce the spread of micropollutants in the environment.
publishDate 2021
dc.date.none.fl_str_mv 2021-05-23T15:52:55Z
2022-09-19
2022-09-19T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://hdl.handle.net/10400.14/33167
url http://hdl.handle.net/10400.14/33167
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 0959-3330
10.1080/09593330.2021.1921048
85106536563
33902395
000654258800001
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv mluisa.alvim@gmail.com
_version_ 1817547001693208576